MEPERIDINE HYDROCHLORIDE Drug Patent Profile
When do Meperidine Hydrochloride patents expire, and when can generic versions of Meperidine Hydrochloride launch?
Meperidine Hydrochloride is a drug marketed by Abbott, Baxter Hlthcare, Igi Labs Inc, Intl Medication, Parke Davis, Watson Labs, West-ward Pharms Int, Hikma, Barr, Duramed Pharms Barr, Epic Pharma Llc, Genus, Specgx Llc, Strides Pharma Intl, Sun Pharm Inds Inc, Sun Pharm Industries, Wyeth Ayerst, Hospira, and Icu Medical Inc. and is included in forty-two NDAs.
The generic ingredient in MEPERIDINE HYDROCHLORIDE is meperidine hydrochloride. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meperidine Hydrochloride
A generic version of MEPERIDINE HYDROCHLORIDE was approved as meperidine hydrochloride by HIKMA on January 30th, 1985.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEPERIDINE HYDROCHLORIDE?
- What are the global sales for MEPERIDINE HYDROCHLORIDE?
- What is Average Wholesale Price for MEPERIDINE HYDROCHLORIDE?
Summary for MEPERIDINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 42 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| Clinical Trials: | 78 |
| Patent Applications: | 3,184 |
| DailyMed Link: | MEPERIDINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MEPERIDINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cukurova University | NA |
| Ondokuz Mays University | NA |
| Tanta University | NA |
Pharmacology for MEPERIDINE HYDROCHLORIDE
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for MEPERIDINE HYDROCHLORIDE
US Patents and Regulatory Information for MEPERIDINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genus | MEPERIDINE HYDROCHLORIDE | meperidine hydrochloride | TABLET;ORAL | 040893-003 | Jun 24, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | MEPERIDINE HYDROCHLORIDE | meperidine hydrochloride | SYRUP;ORAL | 088744-001 | Jan 30, 1985 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharm Inds Inc | MEPERIDINE HYDROCHLORIDE | meperidine hydrochloride | TABLET;ORAL | 040446-001 | Aug 8, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE | meperidine hydrochloride | INJECTABLE;INJECTION | 073443-001 | Mar 17, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
